These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5565432)

  • 21. A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.
    Wilkinson PR; Raftery EB
    Br J Clin Pharmacol; 1977 Jun; 4(3):289-94. PubMed ID: 332218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nifedipine in the emergency and chronic treatment of arterial hypertension].
    Nartowicz E; Burduk P; Karwowski J
    Kardiol Pol; 1987; 30 Suppl():15-21. PubMed ID: 3454381
    [No Abstract]   [Full Text] [Related]  

  • 23. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
    Hollifield JW; Sherman K; Zwagg RV; Shand DG
    N Engl J Med; 1976 Jul; 295(2):68-73. PubMed ID: 775330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practolol-propranolol. A comparison of antihypertensive effect.
    Andersson O; Berglund G
    Acta Med Scand; 1974 Dec; 196(6):479-82. PubMed ID: 4617491
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug combinations as rational antihypertensive therapy.
    Gifford RW
    Arch Intern Med; 1974 Jun; 133(6):1053-7. PubMed ID: 4151443
    [No Abstract]   [Full Text] [Related]  

  • 26. Adrenergic blockade with phenoxybenzamine and propranolol in a cohort of 60 patients undergoing surgery for phaeochromocytoma.
    Mihai R; Sadler GP; Bridge H
    Eur J Anaesthesiol; 2008 Jun; 25(6):508-10. PubMed ID: 18447966
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 28. [The pharmacokinetics of propranolol and its conjugated metabolites in patients with chronic ischemic heart disease and arterial hypertension with a one-time and course intake of the drug].
    Belolipetskaia VG; Rumiantsev DS; Piotrovskiĭ VK; Metelitsa VI; Duda SG; Ostrovskaia TP; Kokurina EV; Martseva SIu; Bochkareva EV; Filatova NP
    Eksp Klin Farmakol; 1995; 58(6):56-9. PubMed ID: 8704616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
    Mroczek WJ; Fotiu S; Davidov ME; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):769-77. PubMed ID: 4217243
    [No Abstract]   [Full Text] [Related]  

  • 30. Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.
    Bühler FR; Laragh JH; Vaughan ED; Brunner HR; Gavras H; Baer L
    Am J Cardiol; 1973 Sep; 32(4):511-22. PubMed ID: 4729721
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute intermittent porphyria: response of tachycardia and hypertension to propranolol.
    Beattie AD; Moore MR; Goldberg A; Ward RL
    Br Med J; 1973 Aug; 3(5874):257-60. PubMed ID: 4723462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New antihypertensive agents. 3. Propranolol].
    Amery A; Deruyttere M
    Acta Clin Belg; 1972; 27(1):447-56. PubMed ID: 4149891
    [No Abstract]   [Full Text] [Related]  

  • 33. Dose related blood pressure response and plasma propranolol levels in essential hypertension.
    Som C; Bhattacharya SK; Singh NK; Gode KD
    Indian Heart J; 1984; 36(1):20-2. PubMed ID: 6706361
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of antihypertensive therapy on renal function in nephrogenic hypertension].
    Figarov IG; Dzhavad-Zade SM
    Urol Nefrol (Mosk); 1998; (3):27-9. PubMed ID: 9644986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on organic nitrates, Part VI. Synthesis and pharmacological activity of 1-isopropylamino-3-(1-naphthyloxy)-2-propyl nitrate.
    Korzycka L; Owczarek J; Czarnecka E
    Acta Pol Pharm; 2002; 59(5):365-9. PubMed ID: 12602798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enalapril in essential hypertension.
    Herrera-Acosta J; Pérez-Grovas H; Fernández M; Arriaga J
    Drugs; 1985; 30 Suppl 1():35-46. PubMed ID: 2994986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
    Ostapiuk FE; Khvoĭnitskiĭ VA
    Sov Med; 1984; (5):87-9. PubMed ID: 6147019
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension in older patients: what drugs to use and when.
    Caris TN
    Geriatrics; 1982 Mar; 37(3):38-43. PubMed ID: 7067974
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of 'responders' to long-term pindolol therapy from phasic changes in cardiovascular function during acute intravenous administration in essential hypertension.
    Logan AG; Milne BJ; Colman JM
    Clin Invest Med; 1978; 1(3-4):147-52. PubMed ID: 42504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.